{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:41Z","timestamp":1787022101465,"version":"build-2736575974"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG030142"],"award-info":[{"award-number":["R01 AG030142"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute","award":["NCI CCSG P30 CA060553"],"award-info":[{"award-number":["NCI CCSG P30 CA060553"]}]},{"name":"The Baila Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Dysregulation of calcium homeostasis has been hypothesized to play a role in Alzheimer\u2019s disease (AD) pathogenesis. Increased calcium levels can impair axonal transport, disrupt synaptic transmission, and ultimately lead to cell death. Given the potential role of calcium dyshomeostasis in AD, there is interest in testing the ability of already approved drugs targeting various calcium channels to affect amyloid pathology and other aspects of disease. The objective of this study was to test the effects of FDA-approved L-type calcium channel antagonist nimodipine on amyloid accumulation and dystrophic neurite formation in 5XFAD mice, a mouse model of amyloid pathology. 5XFAD transgenic mice and non-transgenic littermates were treated with vehicle or nimodipine-containing chow from two to eight months of age, then brains were harvested and amyloid pathology assessed by immunoblot and immunofluorescence microscopy analyses. Nimodipine was well tolerated and crossed the blood brain barrier, as expected, but there was no effect on A\u03b2 accumulation or on the relative amount of neuritic dystrophy, as assessed by either immunoblot, dot blot or immunofluorescence imaging of A\u03b242 and dystrophic neurite marker LAMP1. While we conclude that nimodipine treatment is not likely to improve amyloid pathology or decrease neuritic dystrophy in AD, it is worth noting that nimodipine did not worsen the phenotype suggesting its use is safe in AD patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0263332","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:38:45Z","timestamp":1643809125000},"page":"e0263332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8310-841X","authenticated-orcid":true,"given":"Katherine R.","family":"Sadleir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammaarah","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"issue":"3","key":"pone.0263332.ref001","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-190507","article-title":"Developing Effective Alzheimer\u2019s Disease Therapies: Clinical Experience and Future Directions","volume":"71","author":"DR Elmaleh","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"pone.0263332.ref002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","volume":"179","author":"JM Long","year":"2019","journal-title":"Cell"},{"issue":"6","key":"pone.0263332.ref003","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (Asp 2) as beta-secretase","volume":"14","author":"I Hussain","year":"1999","journal-title":"Molecular and cellular neurosciences"},{"issue":"6761","key":"pone.0263332.ref004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"S Sinha","year":"1999","journal-title":"Nature"},{"issue":"5440","key":"pone.0263332.ref005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"R Vassar","year":"1999","journal-title":"Science"},{"issue":"6761","key":"pone.0263332.ref006","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","article-title":"Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity","volume":"402","author":"R Yan","year":"1999","journal-title":"Nature"},{"issue":"6","key":"pone.0263332.ref007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"DJ Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"pone.0263332.ref008","first-page":"7","volume-title":"Handbook of studies on psychiatry and old age","author":"ZS Khachaturian","year":"1984"},{"issue":"2","key":"pone.0263332.ref009","article-title":"Calcium Hypothesis of Alzheimer\u2019s disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis","volume":"13","author":"Alzheimer\u2019s Association Calcium Hypothesis W","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"17","key":"pone.0263332.ref010","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"A Demuro","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0263332.ref011","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","article-title":"Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors","volume":"47","author":"E Alberdi","year":"2010","journal-title":"Cell Calcium"},{"issue":"4","key":"pone.0263332.ref012","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.4771-07.2008","article-title":"Amyloid beta oligomers (A beta(1\u201342) globulomer) suppress spontaneous synaptic activity by inhibition of P\/Q-type calcium currents","volume":"28","author":"V Nimmrich","year":"2008","journal-title":"J Neurosci"},{"issue":"22","key":"pone.0263332.ref013","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"MA Busche","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5896","key":"pone.0263332.ref014","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"321","author":"MA Busche","year":"2008","journal-title":"Science"},{"issue":"2","key":"pone.0263332.ref015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","article-title":"Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks","volume":"59","author":"KV Kuchibhotla","year":"2008","journal-title":"Neuron"},{"issue":"43","key":"pone.0263332.ref016","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1523\/JNEUROSCI.1836-13.2013","article-title":"Mitochondrial alterations near amyloid plaques in an Alzheimer\u2019s disease mouse model","volume":"33","author":"H Xie","year":"2013","journal-title":"J Neurosci"},{"issue":"2","key":"pone.0263332.ref017","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer\u2019s disease","volume":"132","author":"KR Sadleir","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"6","key":"pone.0263332.ref018","doi-asserted-by":"crossref","first-page":"E1279","DOI":"10.1073\/pnas.1714409115","article-title":"Intracellular Ca(2+) stores control in vivo neuronal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"115","author":"C Lerdkrai","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25","key":"pone.0263332.ref019","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1523\/JNEUROSCI.1554-10.2010","article-title":"Role of presenilins in neuronal calcium homeostasis","volume":"30","author":"H Zhang","year":"2010","journal-title":"J Neurosci"},{"key":"pone.0263332.ref020","first-page":"439","article-title":"Clinical findings with nimodipine in dementia: test of the calcium hypothesis","volume":"46","author":"J Fritze","year":"1995","journal-title":"J Neural Transm Suppl"},{"issue":"10","key":"pone.0263332.ref021","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-3223(90)90050-C","article-title":"Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia","volume":"27","author":"GD Tollefson","year":"1990","journal-title":"Biol Psychiatry"},{"issue":"9137","key":"pone.0263332.ref022","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"F Forette","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"pone.0263332.ref023","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1523\/JNEUROSCI.11-04-01032.1991","article-title":"Distribution of Ca2+ channels on frog motor nerve terminals revealed by fluorescent omega-conotoxin","volume":"11","author":"MW Cohen","year":"1991","journal-title":"J Neurosci"},{"issue":"4","key":"pone.0263332.ref024","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1083\/jcb.123.4.949","article-title":"Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits","volume":"123","author":"JW Hell","year":"1993","journal-title":"J Cell Biol"},{"issue":"6290","key":"pone.0263332.ref025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/347281a0","article-title":"Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons","volume":"347","author":"RE Westenbroek","year":"1990","journal-title":"Nature"},{"issue":"4","key":"pone.0263332.ref026","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1157.1992.tb02358.x","article-title":"Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures","volume":"33","author":"JG Larkin","year":"1992","journal-title":"Epilepsia"},{"issue":"8","key":"pone.0263332.ref027","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/10641960802580232","article-title":"Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies","volume":"30","author":"D Tomassoni","year":"2008","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"pone.0263332.ref028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-199611040-00001","article-title":"Nimodipine in the Treatment of Probable Alzheimer\u2019s Disease: Results of Two Multicentre Trials","volume":"11","author":"F BF Morich","year":"1996","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"pone.0263332.ref029","first-page":"CD000147","article-title":"Nimodipine for primary degenerative, mixed and vascular dementia","author":"JM Lopez-Arrieta","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"44","key":"pone.0263332.ref030","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1523\/JNEUROSCI.0617-19.2019","article-title":"Amyloid-Beta Modulates Low-Threshold Activated Voltage-Gated L-Type Calcium Channels of Arcuate Neuropeptide Y Neurons Leading to Calcium Dysregulation and Hypothalamic Dysfunction","volume":"39","author":"M Ishii","year":"2019","journal-title":"J Neurosci"},{"issue":"40","key":"pone.0263332.ref031","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"H Oakley","year":"2006","journal-title":"J Neurosci"},{"issue":"14","key":"pone.0263332.ref032","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer\u2019s disease pathogenesis","volume":"27","author":"J Zhao","year":"2007","journal-title":"J Neurosci"},{"issue":"5","key":"pone.0263332.ref033","first-page":"669","article-title":"Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease","volume":"37","author":"MS Langley","year":"1989","journal-title":"Drugs"},{"issue":"1","key":"pone.0263332.ref034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11906-012-0319-y","article-title":"The \"his and hers\" of the renin-angiotensin system","volume":"15","author":"LM Hilliard","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"pone.0263332.ref035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2042-6410-3-7","article-title":"Sex differences in primary hypertension","volume":"3","author":"K Sandberg","year":"2012","journal-title":"Biol Sex Differ"},{"key":"pone.0263332.ref036","article-title":"Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer\u2019s disease amyloid plaques","author":"S Gowrishankar","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"pone.0263332.ref037","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","article-title":"The Alzheimer\u2019s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques","volume":"126","author":"PC Kandalepas","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"4","key":"pone.0263332.ref038","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy","volume":"90","author":"P Yuan","year":"2016","journal-title":"Neuron"},{"key":"pone.0263332.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-10-1","article-title":"Abeta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level","volume":"10","author":"KR Sadleir","year":"2015","journal-title":"Molecular neurodegeneration"},{"issue":"7","key":"pone.0263332.ref040","doi-asserted-by":"crossref","first-page":"e101643","DOI":"10.1371\/journal.pone.0101643","article-title":"Genetic inhibition of phosphorylation of the translation initiation factor eIF2alpha does not block Abeta-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"KR Sadleir","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"pone.0263332.ref041","doi-asserted-by":"crossref","first-page":"e1006962","DOI":"10.1371\/journal.pgen.1006962","article-title":"A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer\u2019s disease","volume":"13","author":"A Rocchi","year":"2017","journal-title":"PLoS Genet"},{"issue":"4","key":"pone.0263332.ref042","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205018666210713125333","article-title":"Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice","volume":"18","author":"KR Sadleir","year":"2021","journal-title":"Curr Alzheimer Res"},{"key":"pone.0263332.ref043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/srep00019","article-title":"Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition","volume":"1","author":"C Condello","year":"2011","journal-title":"Sci Rep"},{"issue":"6674","key":"pone.0263332.ref044","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","article-title":"Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial","volume":"298","author":"JD Pickard","year":"1989","journal-title":"BMJ"},{"issue":"3","key":"pone.0263332.ref045","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/foc.2006.21.3.4","article-title":"Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage","volume":"21","author":"RG Mesis","year":"2006","journal-title":"Neurosurg Focus"},{"key":"pone.0263332.ref046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuro.2013.03.011","article-title":"Dietary nimodipine delays the onset of methylmercury neurotoxicity in mice","volume":"37","author":"JM Bailey","year":"2013","journal-title":"Neurotoxicology"},{"key":"pone.0263332.ref047","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuro.2016.04.009","article-title":"A microstructural analysis distinguishes motor and motivational influences over voluntary running in animals chronically exposed to methylmercury and nimodipine","volume":"54","author":"DJ Hoffman","year":"2016","journal-title":"Neurotoxicology"},{"issue":"1","key":"pone.0263332.ref048","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","article-title":"Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine","volume":"9","author":"P Chiozzi","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0263332.ref049","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/gps.1851","article-title":"Nilvadipine prevents cognitive decline of patients with mild cognitive impairment","volume":"22","author":"H Hanyu","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"pone.0263332.ref050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fphar.2020.00562","article-title":"Verapamil and Alzheimer\u2019s Disease: Past, Present, and Future","volume":"11","author":"N Popovic","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"pone.0263332.ref051","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","article-title":"BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice","volume":"26","author":"M Ohno","year":"2007","journal-title":"Neurobiol Dis"},{"key":"pone.0263332.ref052","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fgene.2019.00035","article-title":"Identification of Pre-symptomatic Gene Signatures That Predict Resilience to Cognitive Decline in the Genetically Diverse AD-BXD Model","volume":"10","author":"SM Neuner","year":"2019","journal-title":"Front Genet"},{"issue":"4","key":"pone.0263332.ref053","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.trci.2017.08.002","article-title":"An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations","volume":"3","author":"SJ Sha","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"539","key":"pone.0263332.ref054","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay0167","article-title":"Early delivery and prolonged treatment with nimodipine prevents the development of spasticity after spinal cord injury in mice","volume":"12","author":"M Marcantoni","year":"2020","journal-title":"Sci Transl Med"},{"issue":"16","key":"pone.0263332.ref055","doi-asserted-by":"crossref","first-page":"E3295","DOI":"10.1073\/pnas.1620052114","article-title":"Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis","volume":"114","author":"A Schampel","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"pone.0263332.ref056","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42466-019-0026-0","article-title":"An unmet clinical need: roads to remyelination in MS","volume":"1","author":"P Gottle","year":"2019","journal-title":"Neurol Res Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0263332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:39:32Z","timestamp":1643809172000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0263332"}},"subtitle":[],"editor":[{"given":"Wataru","family":"Araki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0263332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]}}}